The Frequency of Specific Complications Depending on the Method of Surgical Treatment for Diffuse Toxic Goiter
Keywords:
strumectomy, thyroid gland, hypothyroidism, hypoparathyroidism, diffuse toxic goiterAbstract
The authors analyze the frequency of specific complications and the main causes of the complicated course of the early and late period after surgical treatment of DTG.
The authors conclude that the use of an improved method of surgical access to the thyroid gland and a program of postoperative rehabilitation made it possible to reduce the frequency of specific complications, which in general ensured an increase in the proportion of good and satisfactory results from 84.7% to 97.3% with a decrease in the probability of an unsatisfactory outcome from 15 .3% to 2.7%.
References
Aliboev M.R. Abstract of diss. PhD Clinical, functional features, and differentiated tactics of surgical treatment of patients with diffuse toxic goiter Tashkent 2021
Nishonov F.N. Ways to improve the results of surgical treatment of patients with thyroid diseases. Bulletin of TMA 2021 No. 1. 172p.
Dedov, I.I. Endocrinology // - M.: GEOTAR-Media, 2008. - 432 p.
Kochergina, I.I. Diffuse toxic goiter // Therapy. - 2015. - No. 4 (4). - S. 6-11.
Solodkiy, V.A. High-dose radioiodine therapy for Graves' disease // Bulletin of the Russian Scientific Center for Radiology of the Ministry of Health of Russia. - 2013. - T. 4. - No. 13. - P. 11
Troshina, E.A. Principles of thyrostatic therapy of Graves' disease (lecture) // Сonsilium medicum. - 2012. - T. 12. - No. 12. - S. 64-68.
Tsurkan, A.Yu. Evaluation of the influence of various factors on the outcome of subtotal resection of the thyroid gland in Graves' disease. Clinical and experimental thyroidology. - 2011. - T. 7. - No. 1. - S. 50-54.
Sheremeta, M.S. Clinical course of endocrine ophthalmopathy in Graves' disease depending on the effect of radioiodine therapy // Problems of Endocrinology. - 2011. - No. 3. - P. 17–20.
Aoki, Y. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey // Thyroid. - 2007. - Vol. 17. - P. 1211-1223.
Gullo, D. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients // PLoS One. - 2011. - Vol. 6.-Is. 8.-e22552. – P. 1-7.
Hovens, G.C.J. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with, de novo Graves’ disease // Clin. Endocrinol. - 2006. - N. 4. - P. 429-435.
Noguchi, H. Surgical management of Grave’s disease, past and future // 12th Congress of Asian Association of Endocrine Surgeons, 2010. – March 23–24.
